Chimeric antigen receptor T-cell therapy for T-ALL and AML

Non-B-cell acute leukemia is a term that encompasses T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML). Currently, the therapeutic effectiveness of existing treatments for refractory or relapsed (R/R) non-B-cell acute leukemia is limited. In such situations, chimeric antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wenwen, Yang, Dong, Chen, Xi, Liang, Dandan, Zou, Liqun, Zhao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745195/
https://www.ncbi.nlm.nih.gov/pubmed/36523990
http://dx.doi.org/10.3389/fonc.2022.967754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745195/
https://www.ncbi.nlm.nih.gov/pubmed/36523990
http://dx.doi.org/10.3389/fonc.2022.967754

Ejemplares similares